Related references
Note: Only part of the references are listed.Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
Renu R. Bahadoer et al.
LANCET ONCOLOGY (2021)
Association Between Surgical Technical Skill and Long-term Survival for Colon Cancer
Brian C. Brajcich et al.
JAMA ONCOLOGY (2021)
Primary Tumor Resection Plus Chemotherapy Versus Chemotherapy Alone for Colorectal Cancer Patients With Asymptomatic, Synchronous Unresectable Metastases (JCOG1007; iPACS): A Randomized Clinical Trial
Yukihide Kanemitsu et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23) : a multicentre, randomised, open-label, phase 3 trial
Thierry Conroy et al.
LANCET ONCOLOGY (2021)
Primary Tumor Resection for Rectal Cancer With Unresectable Liver Metastases: A Chance to Cut Is a Chance for Improved Survival
Jia-nan Chen et al.
FRONTIERS IN ONCOLOGY (2021)
Capecitabine Versus Active Monitoring in Stable or Responding Metastatic Colorectal Cancer After 16 Weeks of First-Line Therapy: Results of the Randomized FOCUS4-N Trial
Richard A. Adams et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Imaging and Management of Rectal Cancer
Supreeta Arya et al.
SEMINARS IN ULTRASOUND CT AND MRI (2020)
The Role of Maintenance Strategies in Metastatic Colorectal Cancer A Systematic Review and Network Meta-analysis of Randomized Clinical Trials
Mohamad Bassam Sonbol et al.
JAMA ONCOLOGY (2020)
Preliminary results of the organ preservation of rectal adenocarcinoma (OPRA) trial.
Julio Garcia-Aguilar et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
Rectal Cancer, Version 6.2020 Featured Updates to the NCCN Guidelines
Al B. Benson et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)
Challenges and solutions in the design and execution of the PROSPECT Phase II/III neoadjuvant rectal cancer trial (NCCTG N1048/Alliance)
Deborah Schrag et al.
CLINICAL TRIALS (2019)
Standardised reports with a template format are superior to free text reports: the case for rectal cancer reporting in clinical practice
P. J. Brown et al.
EUROPEAN RADIOLOGY (2019)
MRI of Rectal Cancer: Tumor Staging, Imaging Techniques, and Management
Natally Horvat et al.
RADIOGRAPHICS (2019)
Definition of the Rectum An International, Expert-based Delphi Consensus
Nigel D'Souza et al.
ANNALS OF SURGERY (2019)
Randomized Phase II Trial of Chemoradiotherapy Plus Induction or Consolidation Chemotherapy as Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: CAO/ARO/AIO-12
Emmanouil Fokas et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meeting
Regina G. H. Beets-Tan et al.
EUROPEAN RADIOLOGY (2018)
Use of magnetic resonance imaging in rectal cancer patients: Society of Abdominal Radiology (SAR) rectal cancer disease-focused panel (DFP) recommendations 2017
Marc J. Gollub et al.
ABDOMINAL RADIOLOGY (2018)
Trends in presentation, treatment and survival of 1777 patients with colorectal cancer over a decade: a Biobank study
Eetu Heerva et al.
ACTA ONCOLOGICA (2018)
Young-Onset Colorectal Cancer: Earlier Diagnoses or Increasing Disease Burden?
Caitlin C. Murphy et al.
GASTROENTEROLOGY (2017)
Colorectal Cancer Incidence Patterns in the United States, 1974-2013
Rebecca L. Siegel et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trial
Johan Erlandsson et al.
LANCET ONCOLOGY (2017)
Colorectal Cancer Incidence Patterns in the United States, 1974-2013
Rebecca L. Siegel et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2017)
The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging
Mahul B. Amin et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2017)
Effect of Interval (7 or 11 weeks) Between Neoadjuvant Radiochemotherapy and Surgery on Complete Pathologic Response in Rectal Cancer: A Multicenter, Randomized, Controlled Trial (GRECCAR-6)
Jeremie H. Lefevre et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Chemoradiation, surgery and adjuvant chemotherapy versus induction chemotherapy followed by chemoradiation and surgery: long-term results of the Spanish GCR-3 phase II randomized trial
C. Fernandez-Martos et al.
ANNALS OF ONCOLOGY (2015)
Local Resection Compared With Radical Resection in the Treatment of T1N0M0 Rectal Adenocarcinoma: A Systematic Review and Meta-analysis
Biniam Kidane et al.
DISEASES OF THE COLON & RECTUM (2015)
Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial
Carmen J. Allegra et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial
Julio Garcia-Aguilar et al.
LANCET ONCOLOGY (2015)
Maintenance strategies after first-line oxaliplatin plus fluoropyrimidine plus bevacizumab for patients with metastatic colorectal cancer (AIO 0207): a randomised, non-inferiority, open-label, phase 3 trial
Susanna Hegewisch-Becker et al.
LANCET ONCOLOGY (2015)
Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial
Claus Roedel et al.
LANCET ONCOLOGY (2015)
Neoadjuvant 5-FU or Capecitabine Plus Radiation With or Without Oxaliplatin in Rectal Cancer Patients: A Phase III Randomized Clinical Trial
Carmen J. Allegra et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2015)
Comparison of Transanal Endoscopic Microsurgery and Total Mesorectal Excision in the Treatment of T1 Rectal Cancer: A Meta-Analysis
Jun-Yang Lu et al.
PLOS ONE (2015)
Oxaliplatin, fluorouracil, and leucovorin versus fluorouracil and leucovorin as adjuvant chemotherapy for locally advanced rectal cancer after preoperative chemoradiotherapy (ADORE): an open-label, multicentre, phase 2, randomised controlled trial
Yong Sang Hong et al.
LANCET ONCOLOGY (2014)
Preoperative Versus Postoperative Chemoradiotherapy for Locally Advanced Rectal Cancer: Results of the German CAO/ARO/AIO-94 Randomized Phase III Trial After a Median Follow-Up of 11 Years
Rolf Sauer et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Primary Tumor Response to Preoperative Chemoradiation With or Without Oxaliplatin in Locally Advanced Rectal Cancer: Pathologic Results of the STAR-01 Randomized Phase III Trial
Carlo Aschele et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial
Willem van Gijn et al.
LANCET ONCOLOGY (2011)
Transanal endoscopic microsurgery for 135 patients with small nonadvanced low rectal cancer (iT1-iT2, iN0): short- and long-term results
Giovanni Lezoche et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2011)
Phase II, Randomized Study of Concomitant Chemoradiotherapy Followed by Surgery and Adjuvant Capecitabine Plus Oxaliplatin (CAPOX) Compared With Induction CAPOX Followed by Concomitant Chemoradiotherapy and Surgery in Magnetic Resonance Imaging-Defined, Locally Advanced Rectal Cancer: Grupo Cancer de Recto 3 Study
Carlos Fernandez-Martos et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
Worldwide Variations in Colorectal Cancer
Melissa M. Center et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2009)
Preoperative Multimodality Therapy Improves Disease-Free Survival in Patients With Carcinoma of the Rectum: NSABP R-03
Mark S. Roh et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
Bernard Nordlinger et al.
LANCET (2008)
Patients with curative resection of cT3-4 rectal cancer after Preoperative radiotherapy or radiochemotherapy:: Does anybody benefit from adjuvant fluorouracil-based chemotherapy?: A trial of the European organisation for research and treatment of cancer radiation oncology group
Laurence Collette et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Chemotherapy with preoperative radiotherapy in rectal cancer
Jean-Francois Bosset et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Enhanced tumorocidal effect of chemotherapy with preoperative radiotherapy for rectal cancer: Preliminary results - EORTC 22921
JF Bosset et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Transanal endoscopic vs total mesorectal laparoscopic resections of T2-N0 low rectal cancers after neoadjuvant treatment -: A prospective randomized trial with a 3-year minimum follow-up period
E Lezoche et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2005)
Long-term results of patients with pT2 rectal cancer treated with radiotherapy and transanal endoscopic microsurgical excision
E Lezoche et al.
WORLD JOURNAL OF SURGERY (2002)
Share Paper
